Segall Bryant & Hamill’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.4M | Buy |
148,614
+3,277
| +2% | +$450K | 0.29% | 116 |
|
2025
Q1 | $26.2M | Sell |
145,337
-3,972
| -3% | -$716K | 0.4% | 75 |
|
2024
Q4 | $23.4M | Sell |
149,309
-7,835
| -5% | -$1.23M | 0.32% | 97 |
|
2024
Q3 | $28.6M | Buy |
157,144
+122,407
| +352% | +$22.3M | 0.39% | 79 |
|
2024
Q2 | $6.38M | Buy |
+34,737
| New | +$6.38M | 0.11% | 243 |
|